Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
Americas
Clear all
Type of publications
NITAG documentation
(105)
Scientific publications
(3)
Systematic reviews (SYSVAC)
(8)
Topics
Regions
Americas
(116)
South-East Asia
(9)
Countries
Canada
(116)
Argentina
(30)
Bolivia
(3)
Brazil
(4)
Chile
(66)
Colombia
(1)
Costa Rica
(1)
Honduras
(14)
Mexico
(1)
Nicaragua
(1)
Peru
(2)
United States of America
(430)
Uruguay
(2)
Diseases
COVID-19
(41)
Diphtheria
(2)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(20)
Measles
(1)
Meningococcal disease
(7)
Mpox // Monkeypox
(2)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(7)
Rabies
(1)
Rotavirus
(2)
Rubella
(1)
Tuberculosis
(1)
Varicella
(4)
Publication date
2024
(1)
2023
(11)
2022
(21)
2021
(19)
2020
(10)
2019
(4)
2018
(5)
2017
(4)
2016
(3)
2015
(6)
2014
(8)
2013
(1)
2010
(11)
2009
(4)
2008
(5)
2006
(1)
2005
(1)
Target population
Adolescents
(2)
Adults
(5)
All age groups
(6)
Children
(1)
Healthcare workers
(3)
Newborn
(1)
Older adults
(5)
Parents/caregivers
(1)
Pregnant women
(2)
Available to download in languages
English (EN)
(91)
French (FR)
(38)
116 results found
2024
∙
NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
2023
∙
Matthew Tunis, Shelley Deeks, Caroline Quach, Marina Salvadori, Bryna Warshawsky, Kelsey Young, Shainoor Ismail, Christine Mauviel, Erin Henry
Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
2023
∙
NACI
Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19
2023
∙
NACI, Anne Pham-Huy, Joseline Zafack, Courtney Primeau, Oliver Baclic, Marina Salvadori, Shelley Deeks
A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure
2023
∙
NACI
Guidance on the use of COVID-19 vaccines in the fall of 2023
2023
∙
NACI
NACI Interim guidance on the use of bivalent Omicroncontaining COVID-19 vaccines for primary series
2023
∙
NACI
Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
2023
∙
NACI
Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2023
∙
NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register